Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

GILD (Common Stock)
Exchange	NASDAQ (US Dollar)
Price	$33.32
Change (%)	0.09 (0.27%)
Volume	10,965,087
Data as of 07/30/10 4:00 p.m. ET Minimum 20 minute delay Refresh quote

Recent News

More >>

Date	Title
07/30/10	Gilead Closes Sale of $2.2 Billion of Convertible Senior Notes
07/27/10	Gilead Prices $2.2 Billion of Convertible Senior Notes; Company to Repurchase $1 Billion in Common Stock
07/26/10	Gilead to Offer $2.2 Billion of Convertible Senior Notes; Company to Repurchase $1 Billion in Common Stock

Upcoming Events

More >>

There are currently no events scheduled.

Most Viewed Links

Updated 07/30/10

1.	SEC Filings
2.	Annual Reports
3.	Stock Quote
4.	Fundamentals - Snapshot
5.	Biography

* Data collected 07/02/10 - 07/09/10

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Gilead Sciences posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.